Cases 1 - 10 of 92
Par Pharmaceutical, Inc. et al v. Long Grove Pharmaceuticals, LLC
as 1:2023cv01412
Plaintiff:
Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC
Defendant:
Long Grove Pharmaceuticals, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Par Pharmaceutical, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00866
Plaintiff:
Par Pharmaceutical, Inc. and Epic Par Innovation Company, LLC
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Par Pharmaceutical, Inc. et al v. Baxter Healthcare Corporation
as 1:2023cv00358
Plaintiff:
Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC
Defendant:
Baxter Healthcare Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
as 1:2019cv02216
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
3Rd Party Defendant:
Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Intervenor:
Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Fresenius Kabi USA, LLC
as 1:2019cv01985
Plaintiff:
Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Defendant:
Fresenius Kabi USA, LLC
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. American Regent, Inc.
as 1:2019cv01490
Defendant:
American Regent, Inc.
Plaintiff:
Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Keryx Biopharmaceuticals, Inc. et al v. Par Pharmaceutical, Inc.
as 1:2019cv00955
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Amneal Pharmaceuticals Company GmbH et al
as 1:2019cv00712
Defendant:
Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceutical Holding Company LLC, Amneal Biosciences LLC and others
Plaintiff:
Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc., et al.
as 1:2019cv00311
Defendant:
Par Pharmaceuticals, Inc. and Anchen Pharmaceuticals, Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
